AMANDA LEWIS: Open Payments
NPI 1790072965 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 63 payments from 10 companies in 2025. Trend: 2023 $734 · 2024 $1,211 · 2025 $1,119
Food & beverage: $1,010Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $336 |
| ABBVIE INC. | 18 | $215 |
| Alkermes, Inc. | 5 | $117 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 1 | $97 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Abbott Laboratories | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, PLUVICTO, ARISTADA, UZEDY, COBENFY, Qelbree.
Industry payments across NY — which companies pay providers there.
